Potential Benefits and Drawbacks to Direct-to-Consumer Genetic Testing

5 Pages Posted: 18 Jul 2018

See all articles by Paul Cottrell

Paul Cottrell

affiliation not provided to SSRN

Date Written: March 5, 2018


With the advent of the genomic age we are now able to sequence individual genomes and determine the likelihood of developing a disease state. Due to the lower cost of sequencing DNA at a large scale there has been a plethora of DNA kits for the consumer market. This opens opportunities for direct contact to the consumer about their individual ancestry and potential diseases. These opportunities on the surface seem useful for the consumer, but we must consider the validity of the pathological or non-pathological claims. This direct-to-consumer genetic testing market might need to have better regulatory oversight to maintain validity and quality of the genetic claims. In addition to collecting DNA information on individuals, it is possible to correlate genetic linkage maps on larger population sets to see patterns of disease and potential therapies. With any personal information security is of the upmost importance, especially with individual DNA sequences.

Keywords: DNA Kits, Consumer Testing, DNA Sequencing, Direct-to-Consumer, Genetic Testing

Suggested Citation

Cottrell, Paul, Potential Benefits and Drawbacks to Direct-to-Consumer Genetic Testing (March 5, 2018). Available at SSRN: https://ssrn.com/abstract=3204447 or http://dx.doi.org/10.2139/ssrn.3204447

Paul Cottrell (Contact Author)

affiliation not provided to SSRN

Do you have a job opening that you would like to promote on SSRN?

Paper statistics

Abstract Views
PlumX Metrics